Mark Aloia.
Boulder, USA
Boulder, USA
The Digital Future of Sleep: Building Motivation for Health in the Digital Age
There is no denying that the digital age has come and it has begun to involve a focus on health behaviors. More and more people are engaging in monitoring health behaviors, including sleep. But, are we optimizing the focus on digital monitoring and therapeutics in ways that can reduce costs, increase engagement and improve outcomes? We will discuss briefly the example of OSA and how industry and clinical partners can approach healthy sleep in the digital age. Changing from our traditional medical approach is not easy, but it may infect be the right thing to do to manage outrageous healthcare costs and poor engagement.
Mark Aloia is the Vice President and Global Lead for Behavior Change at Philips HealthTech and an Associate Professor of Medicine at National Jewish Health in Denver, CO. He has also been on the faculty at the University of Rochester and at Brown University as a prominent health researcher. Dr. Aloia has studied health behavior change for the past 20 years and maintains NIH funding through his academic work, with over $15M in funding to study health behavior change. He serves as an NIH grant reviewer and has published over 50 scientific papers in high quality journals. Dr. Aloia has also served on the Editorial Boards of the journals Sleep, Health Psychology, and Behavioral Sleep Medicine. He has edited a book on Behavioral Treatment for Sleep Disorders that has been translated into multiple languages. He is a regular blogger on Healthy Living for the Huffington Post.
Dr. Aloia’s focus on behavioral methods to improve adherence to treatment has made significant contributions to the sleep and health psychology fields. His studies include a strong focus on promoting positive health behaviors using theoretical models of behavior change and bringing theory into practice by incorporating these ideas into mobile applications and new sensor technology. His work at Philips has resulted in products and services that have demonstrated effects on health outcomes and help differentiate the company as a developer with empirically tested health outcomes.